Given that the most pronounced differential expression of SHROOM4 was observed in LUSC among various cancer types, we further validated the reduced mRNA and protein expression of SHROOM4 in LUSC through quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC). Here, SHROOM4 is linked to cancer.